Mid-Intensity 30.5 GHz Continuous Wave Exposure of Glioblastoma Organoids

Le résumé fourni par la source

In this chapter, we delve into the therapeutic potential of 30.5 GHz millimeter waves on 3D glioblastoma organoids. We specifically investigated mild thermal radiation effects in the context of new emerging focused energy delivery and bioelectromagnetic approaches. Our in-house developed exposure system, coupled with a rigorous dosimetry protocol and extensive multi-physics modeling, supported biological endpoint evaluation in terms of transcriptional profiling, cell morphological changes, and cell phenotypic characterization. Crucially, the induced thermal effect was minimal, aligning closely with our simulation models and indicating the precise control of energy delivery. Notably, a 0.1 W power level enhanced the efficacy of Temozolomide, significantly increasing cell apoptosis while not affecting the differentiation status of glioblastoma organoid cells. This combination suggests a new avenue for glioblastoma treatment, leveraging millimeter wave-induced mechanisms that warrant further investigation. Our findings underscore the promise of this minimally invasive technique, offering a glimpse into future glioblastoma therapies.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.